Cancer Clinical Trials

252 studies are recruiting for cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 7

  1. Implementation of eHealth Delivery Alternatives for Cancer Genetic Testing for Hereditary Cancer (eREACH3)

    The purpose of the study is to understand patient interest in telehealth and digital tools for pre-test genetic education and/or disclosure of genetic test results. Participants will receive telehealth genetic counseling in the home and may be offered various digital tools to help with the counseli…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania
    Run by
    Abramson Cancer Center at Penn Medicine
  2. Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life

    The goal of this research study is to measure changes in patients' quality of life after surgeries that affect the facial nerve, including nerve transfer as treatment for facial paralysis.

    Stage
    Not phased
    Ages
    18 and older
    Site
    The University of Texas M. D. Anderson Cancer Center, Houston, Texas
    Run by
    M.D. Anderson Cancer Center
  3. Prospective Study to Assess a Diagnostic Aid for Cancer

    The primary objective of this study is to establish the performance of two blood-based diagnostic aid test for cancer detection in individuals presenting with symptoms, signs, or findings suggestive of cancer.

    Stage
    Not phased
    Ages
    45 and older
    Site
    Southern California Research Center, Coronado, California
    Locations
    39 in total
    Run by
    Harbinger Health
  4. A Dose Finding Phase 1 of Sarilumab Plus Capecitabine in HER2/Neu-Negative Metastatic Breast Cancer and a Single-arm, Historically-controlled Phase 2 Study of Sarilumab Plus Capecitabine in Stage I-III Triple Negative Breast Cancer With High-Risk Residual Disease (EMPOWER)

    This study looks to advance a novel and potent strategy to eliminate minimal residual disease (MRD) in triple negative breast cancer (TNBC) present even after multimodal treatment, thereby improving survival and increasing cure rate in this aggressive cancer. Patients with locally advanced TNBC are…

    Stage
    Phase 1
    Ages
    18 to 99
    Site
    Los Angeles General Medical Center, Los Angeles, California
    Locations
    3 in total
    Run by
    University of Southern California
  5. Supportive Care Intervention for Outpatient Stem Cell Transplant Patients

    The overall goal of this study is to assess the efficacy of the care.coach Avatar™ in improving anxiety and quality of life for patients undergoing outpatient transplant. After care.coach Avatar™ content and scheduling ("digital intervention" or "program") has been optimized for outpatient allogene…

    Stage
    Not phased
    Ages
    19 and older
    Site
    Dana-Farber Cancer Institute, Boston, Massachusetts
    Run by
    Victor Wang
  6. Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions

    The purpose of this study is to determine whether a consultation with a Personalized Therapeutics Clinic, or PTC, will help participants lower the risk for side effects (drug-drug interactions and drug-gene interactions) when taking many medications and help providers improve prescribing decisions …

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Chicago Medicine, Chicago, Illinois
    Run by
    University of Chicago
  7. Ovarian Tissue Cryopreservation for Fertility Preservation

    The goal of this observational study is to learn about fertility preservation for pre-pubertal, peri-pubertal, and adult participants that are unable to pursue clinical standard of care fertility preservation such as egg (oocyte) and embryo cryopreservation. In addition, this study will provide res…

    Stage
    Not phased
    Ages
    Up to 39
    Site
    Magee-Womens Hospital, Pittsburgh, Pennsylvania
    Run by
    University of Pittsburgh
  8. Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy

    Daily patient participation is critical to the successful, life-saving delivery of radiotherapy. There is very little in the literature describing the best way to prepare patients to give optimal participation. This study aims to look at an already-prepared conversion of patient instruction materia…

    Stage
    Not phased
    Ages
    18 to 99
    Site
    University of Florida, Gainesville, Florida
    Run by
    University of Florida
  9. Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

    This is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at one 1 or more dosi…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California
    Locations
    17 in total
    Run by
    MBrace Therapeutics
  10. Positron Emission Tomography (PET) Imaging of Thrombosis

    The purpose of the study is to evaluate a new radiotracer called 64Cu-FBP8 for PET-MR imaging of thrombosis. The tracer has the potential of detecting thrombosis anywhere in the body, for instance in the left atrial appendage of patients with atrial fibrillation, and thereby may provide a non-invas…

    Stage
    Phase 1
    Ages
    18 to 85
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Run by
    Massachusetts General Hospital
  11. Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States

    To develop and measure the effects of a culturally sensitive yoga program for inpatients

    Stage
    Not phased
    Ages
    18 and older
    Site
    M D Anderson Cancer Center, Houston, Texas
    Locations
    3 in total
    Run by
    M.D. Anderson Cancer Center
  12. Food and Microbiome Longitudinal Investigation (FAMiLI)

    The NYU Human Microbiome Study Cohort is designed to improve understanding of the role of human microbiome in health and disease. This study will serve as a critical NYU biorepository resource for research on human genetics and the microbiome in health and disease

    Stage
    Not phased
    Ages
    40 and older
    Site
    New York University School of Medicine, New York, New York
    Run by
    NYU Langone Health
  13. Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers

    This is a study in patients with newly diagnosed cancer to prospectively evaluate the feasibility of integration of a visual communication tool for patients/caregivers/providers by determining whether such a tool can increase overall satisfaction with the patient experience.

    Stage
    Not phased
    Ages
    18 to 100
    Site
    NYU Langone Health, New York, New York
    Run by
    NYU Langone Health
  14. Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

    The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible…

    Stage
    Not phased
    Ages
    13 to 39
    Site
    Pediatric Hematology/Oncology Clinic in Smilow Cancer Hospital, New Haven, Connecticut
    Run by
    Yale University
  15. TEMPUS ARIES: A Biobank Registry Platform Study in Oncology

    This study is a non-interventional, multicenter, multicohort evaluation of participants with cancer who will undergo longitudinal plasma ctDNA biomarker profiling at specific time points in addition to standard of care therapy.

    Stage
    Not phased
    Ages
    18 to 99
    Site
    Alabama Oncology, Birmingham, Alabama
    Locations
    32 in total
    Run by
    Tempus AI
  16. Re-Engaging AYA Survivors in Cancer-Related Healthcare

    The goal of this clinical trial is to test the efficacy (how well they work) of different digital interventions that deliver information to adolescent and young adult (AYA) survivors of childhood cancer to promote re-engagement in cancer-related long-term follow-up care (LTFU). The main aims are: *…

    Stage
    Not phased
    Ages
    15 to 29
    Site
    Nationwide Children's Hospital, Columbus, Ohio
    Locations
    3 in total
    Run by
    Children's Hospital of Philadelphia
  17. Prevent Cancer- Greenville

    Prevent Cancer-Greenville was created to provide individuals with the opportunity to have their risk of developing cancer studied. Some individuals may be at a higher risk due to their personal lifestyle, family history and/or exposures. If subjects are found to be at high risk for developing a dis…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Prisma Health-Upstate, Greenville, South Carolina
    Run by
    Prisma Health-Upstate
  18. Rehabilitation Outcomes Study

    This pilot health services interventional study aims to prospectively assess the effectiveness of a pre-treatment rehabilitation (prehabilitation) program across a diverse cohort of adult cancer patients via a randomized pilot trial. Upon screening and identification of high-risk features through a…

    Stage
    Not phased
    Ages
    18 and older
    Site
    The N.C. Cancer Hospital, Chapel Hill, North Carolina
    Run by
    UNC Lineberger Comprehensive Cancer Center
  19. From Screening to Support: A Multi-Method Analysis of HRSN Integration in Cancer Care

    This observational study aims to identify the factors that influence whether cancer patients accept or decline supportive care services after screening positive for health-related social needs (HRSNs) at the Sidney Kimmel Comprehensive Cancer Center. The study focuses on adult oncology patients who…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania
    Run by
    Thomas Jefferson University
  20. Cancer and Mild Cognitive Impairment Dyadic Intervention

    The purpose of this study is to see whether programs that include both a patient and their spouse or a patient and family caregiver (known as a dyad) are helpful for families in which one member of the dyad has cancer and mild memory difficulties and/or concerns. Participant and their spouse or par…

    Stage
    Not phased
    Ages
    18 to 100
    Site
    Duke University, Durham, North Carolina
    Run by
    Duke University
  21. Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)

    This study aims to help patients with cancer facing legal issues. The investigators noticed that many patients struggle with laws and regulations related to disability benefits, employment rules, health insurance denials, and financial assistance barriers among many others. To understand this bette…

    Stage
    Not phased
    Ages
    18 and older
    Site
    The Kirklin Clinic, Birmingham, Alabama
    Run by
    University of Alabama at Birmingham
  22. DOAC - Dosing Options in AntiCoagulation Prophylaxis

    Blood clots, also known as venous thromboembolism (VTE), are a common and serious complication for people with cancer. They can lead to pain, hospitalizations, delayed cancer treatment, and even death. Although national guidelines recommend using blood thinners (anticoagulants) to prevent clots in …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Vermont Medical Center, Burlington, Vermont
    Run by
    University of Vermont
  23. Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural Effusions

    This is a randomized control trial of patients with suspected malignant pleural effusions to compare whether patients who have a thoracentesis or pleuroscopy (pleural biopsy) obtain an adequate biopsy, achieve a diagnosis, and begin cancer-directed therapy faster.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Mount Sinai West, New York, New York
    Locations
    2 in total
    Run by
    Icahn School of Medicine at Mount Sinai
  24. Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning

    This study investigates the impact of four standard of care, monitored group exercise regimens (resistance training) on conditioning and hypertrophy in women previously treated for breast cancer. The study will compare two conditioning regimens (6-12-25 and 8x8) and two hypertrophy regimens (5/5/5 …

    Stage
    Not phased
    Ages
    20 to 89
    Site
    Allegheny General Hospital, Pittsburgh, Pennsylvania
    Run by
    Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
  25. Resistance Training and Post Workout Protein to Improve Body Composition During Neoadjuvant Chemotherapy for Breast Cancer

    In this study, the investigators hypothesize that a high dose of post-workout protein nutrition regimen focused on food quality and an observed exercise regimen utilizing high-load resistance training initiated during or after cancer treatment will improve body composition and functional capacity.

    Stage
    Not phased
    Ages
    20 to 89
    Site
    Allegheny General Hospital, Pittsburgh, Pennsylvania
    Run by
    Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.